NICOLE L. SIMONE, M.D. Inducted into Italian-American National Hall of Fame: a Radiation Oncologist, Research Scientist, and Co-Leader of Sidney Kimmel Cancer Center Program at Jefferson University Hospitals in Philadelphia, PA, and community activist. She was chosen because of her many outstanding accomplishments including cancer research and treatment, especially breast and prostate cancer by integrating a healthy low calorie diet that leads to better outcomes.
CANCER RELATED FATIGUE, FOSTER CHILDREN GIVEN PSYCHOTROPIC DRUGS, FLU VACCINE, GMO, GENETICS, KIDSTART, OAT PRODUCTS AND ROUNDUP – ERSKINE OVERNIGHT INTERVIEW
Dr Simone discusses NUTRITIONAL HYDRATION, SIMONE SUPER ENERGY, FOSTER CHILDREN GIVEN PSYCHOTROPIC DRUGS, FLU VACCINE, GENETICS, KIDSTART, OAT PRODUCTS AND ROUNDUP – ERSKINE OVERNIGHT INTERVIEW
CHARLES B. SIMONE, II, M.D. JOINS THE NEW YORK PROTON CENTER AS CHIEF MEDICAL OFFICER
Internationally recognized as a leading expert in the use of proton therapies, Dr. Simone will be instrumental in opening the Manhattan facility in Spring 2019.
Michael Landon came to Dr Charles Simone for consultation and an integrative approach for his treatment. Michael Landon was Bonanza’s Little Joe, and then he launched two hit series on his own, Little House on the Prairie, and Highway to Heaven. He always specialized in happy endings.
This interview was done in 1996. UNFORTUNATELY, THE INFORMATION IS TIMELESS – BOTH THE TRUTH ABOUT CANCER and THE CONFLICT OF INTEREST BETWEEN BIG PHARMA AND SOME CANCER CENTERS AND SOME PHYSICIANS.
On September 8, 2018 the New York Times and ProPublica reported that Memorial Sloan Kettering Cancer Center’s chief medical officer, Dr. José Baselga, also on the Board of Memorial Sloan-Kettering, failed to disclose millions of dollars’ worth of payments and did not disclose his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet. Treatment recommendations could certainly be influenced by a physician’s or a center’s financial entanglements.
You the taxpayer through Medicaid, paid $366 million for these medications that are not effective and can induce violent behavior.